Psychooncological brief therapeutic intervention for parents of adolescent and young adults (AYA) with hematological malignancies

Psychooncological brief therapeutic intervention for parents of adolescent and young adults (AYA) with hematological malignancies - AYA-PARENTS 2012

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00004259

Enrollment

160

Registered

2012-10-11

Start date

2012-11-23

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

maladaptive coping C81-C96

Interventions

Group 1: The treatment arm 1 includes a five-session psycho-oncological brief intervention (PBI). PBI is based on the psychotherapeutic concepts of psycho-education and supportive psychotherapy. Among

Eligibility

Sex/Gender

All

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: a) acute / chronic hematological malign illness situation (ICD-10-C-diagnosis) AND / OR b) outpatient / inpatient treatment c) ECOG Performance Status = 2 d) Patients 18. – 40. year of age e) acceptable german language f) acceptable cognitive abilities for understanding of diagnosis and treament g) written and verbal study information h) written informed consent

Exclusion criteria

Exclusion criteria: a. treatment mortality b. oral intake of strong sedative or psychotropic medication c. organic brain syndrome

Design outcomes

Primary

Measure	Time frame
adaptive and problem-oriented coping assessed with the adaptive subscales of Brief COPE questionnaire. Measuring points: t0 (baseline), t1 (pre-treatment), t2 (post-treatment), t3 (follow-up, oncological end of treatment, max. 3 months after t0).	—

Secondary

Measure	Time frame
a. maladaptive coping assessed with the maladaptive subscales of the Brief COPE questionnaire b. problems in parental coping/mastery assessed with the subscales "coping/mastery" and "personal negative impact" of the FaBel (Familien-Belastungs-Fragebogen/ Impact on Family Scale) c. depressive symptoms (PHQ-D) d. health-related quality of life (SF-36) further secondary endpoints: e. subjective illness concepts (Brief IPQ) f. helping alliance scales patient/therapist (HAQ) g. subjective prognosis estimation (one item as 6-ary visual analogue-scale) Measuring points: t0 (baseline), t1 (pre-treatment), t2 (post-treatment), t3 (follow-up, oncological end of treatment, max. 3 months after t0).	—

Measure

Time frame

a. maladaptive coping assessed with the maladaptive subscales of the Brief COPE questionnaire b. problems in parental coping/mastery assessed with the subscales "coping/mastery" and "personal negative impact" of the FaBel (Familien-Belastungs-Fragebogen/ Impact on Family Scale) c. depressive symptoms (PHQ-D) d. health-related quality of life (SF-36) further secondary endpoints: e. subjective illness concepts (Brief IPQ) f. helping alliance scales patient/therapist (HAQ) g. subjective prognosis estimation (one item as 6-ary visual analogue-scale) Measuring points: t0 (baseline), t1 (pre-treatment), t2 (post-treatment), t3 (follow-up, oncological end of treatment, max. 3 months after t0).

—

Countries

Germany

Contacts

Public ContactMichael Koehler

Universitätsklinik für Hämatologie und Onkologie

michael.koehler@med.ovgu.de+49 (0) 391-67-13307

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026